نتایج جستجو برای: postprandial hyperglycemia

تعداد نتایج: 28133  

2015
NORIAKI KASUYA SHOICHIRO OHTA YOSHIKAZU TAKANAMI YUKARI KAWAI YUTAKA INOUE ISAMU MURATA IKUO KANAMOTO

Low glycemic index (GI) food and postprandial exercise are non-drug therapies for improving postprandial hyperglycemia. The present randomized, crossover study investigated the effect of low GI food combined with postprandial exercise on postprandial blood glucose level, oxidative stress and antioxidant capacity. A total of 13 healthy subjects were each used in four experiments: i) rice only (c...

Journal: :Diabetes care 2006
M Sue Kirkman R Ravi Shankar Sudha Shankar Changyu Shen Edward Brizendine Alain Baron Janet McGill

OBJECTIVE Postprandial hyperglycemia characterizes early type 2 diabetes. We investigated whether ameliorating postprandial hyperglycemia with acarbose would prevent or delay progression of diabetes, defined as progression to frank fasting hyperglycemia, in subjects with early diabetes (fasting plasma glucose [FPG] <140 mg/dl and 2-h plasma glucose > or =200 mg/dl). RESEARCH DESIGN AND METHOD...

Journal: :Diabetes Care 2009
Antonio Ceriello

In the recent HEART2D (Hyperglycemia and its Effect After Acute Myocardial Infarction on Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus) study, published in this issue of Diabetes Care, Raz et al. (1) try to answer a hotly debated question of the last 10 years: is postprandial hyperglycemia an independent risk factor for cardiovascular disease in diabetes? This question, high...

Journal: :The Journal of clinical investigation 1986
R G Firth P M Bell H M Marsh I Hansen R A Rizza

Patients with noninsulin-dependent diabetes mellitus (NIDDM) have both preprandial and postprandial hyperglycemia. To determine the mechanism responsible for the postprandial hyperglycemia, insulin secretion, insulin action, and the pattern of carbohydrate metabolism after glucose ingestion were assessed in patients with NIDDM and in matched nondiabetic subjects using the dual isotope and forea...

Journal: :Diabetes care 2005
Naila Ahmed Roya Babaei-Jadidi Scott K Howell Paul J Thornalley Paul J Beisswenger

OBJECTIVE To assess the relative importance of fasting and postprandial hyperglycemia to vascular dysfunction in diabetes, we have measured indicators of glycation, oxidative and nitrosative stress in subjects with type 1 diabetes, and different postprandial glucose patterns. RESEARCH DESIGN AND METHODS Plasma and urinary levels of specific arginine- and lysine-derived advanced glycation end ...

2007

Chronic hyperglycemia, usually assessed from HbA1c determinations, results in excessive glycation and generation of oxidative stress. As a consequence, chronic hyperglycemia has been identifi ed as a risk factor for diabetes complications leading to accelerated atherosclerosis. Both fasting and postprandial hyperglycemia contribute to this process. However the acute glucose fl uctuations that o...

Journal: :Circulation 2004
Katherine Esposito Dario Giugliano Francesco Nappo Raffaele Marfella

BACKGROUND Postprandial hyperglycemia may be a risk factor for cardiovascular disease. We compared the effects of two insulin secretagogues, repaglinide and glyburide, known to have different efficacy on postprandial hyperglycemia, on carotid intima-media thickness (CIMT) and markers of systemic vascular inflammation in type 2 diabetic patients. METHODS AND RESULTS We performed a randomized, ...

A GHolamhoseinian F SHarififar H Falah

Background & Aims: Postprandial hyperglycemia results in the development of chronic complications. Therefore, its control is critical in the treatment of diabetes. One of the main therapeutic approaches for reducing postprandial hyperglycemia is to reduce the absorption of carbohydrates by enzyme inhibitors such as Acarbose which have already been clinically used as a medicine for diabetic pati...

Journal: :Biological & pharmaceutical bulletin 2002
Tomoyuki Mine Kyoko Miura Yoshiro Kitahara Akira Okano Ryuzo Kawamori

Postprandial hypertriglyceridemia, as well as postprandial hyperglycemia, are important factors contributing to the development of cardiovascular disease in patients with type 2 diabetes. Nateglinide is a recently approved antidiabetic that suppresses postprandial hyperglycemia by stimulating the early phase of insulin secretion. In the present study, we investigated the effects of nateglinide ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید